Mudgal Kothekar

Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)–Positive Metastatic Breast Cancer

Hope S. Rugo, Abhijit Barve, Cornelius F. Waller et al. · JAMA · 2016 · 142 citations · Full text

Phase 1 Trial of Vodobatinib, a Novel Oral BCR-ABL1 Tyrosine Kinase Inhibitor (TKI): Activity in CML Chronic Phase Patients Failing TKI Therapies Including Ponatinib

Jörge E. Cortes, Tapan Saikia, Dong‐Wook Kim et al. · Blood · 2020 · 34 citations

A pharmacokinetics and pharmacodynamics equivalence trial of the proposed pegfilgrastim biosimilar, MYL-1401H, versus reference pegfilgrastim

Cornelius F. Waller, Renger G. Tiessen, Tracey E. Lawrence et al. · Journal of Cancer Research and Clinical Oncology · 2018 · 30 citations · Full text

Pharmacological Study, Pegfilgrastim Biosimilar, Medicine +4

Intravenous pegylated liposomal prednisolone outperforms intramuscular methylprednisolone in treating rheumatoid arthritis flares: A randomized controlled clinical trial

Josbert M. Metselaar, Leonie M. Middelink, Cornelis H. Wortel et al. · Journal of Controlled Release · 2021 · 30 citations

Inflammation, Rheumatology, Rheumatoid Disorder +11

Randomized phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H in the prophylactic treatment of chemotherapy-induced neutropenia

Cornelius F. Waller, Gopinath Ranganna, Eduardo J. Pennella et al. · Annals of Hematology · 2019 · 25 citations · Full text